Development of a novel human CD147 knock-in NSG mouse model to test SARS-CoV-2 viral infection

被引：0

作者：

Saiaditya Badeti

Qingkui Jiang

Alireza Naghizadeh

Hsiang-chi Tseng

Yuri Bushkin

Salvatore A. E. Marras

Annuurun Nisa

Sanjay Tyagi

Fei Chen

Peter Romanienko

Ghassan Yehia

Deborah Evans

Moises Lopez-Gonzalez

David Alland

Riccardo Russo

William Gause

Lanbo Shi

Dongfang Liu

机构：

[1] Rutgers University,Department of Pathology, Immunology and Laboratory Medicine, Center for Immunity and Inflammation, Rutgers

[2] Rutgers University,New Jersey Medical School

[3] Rutgers University,School of Graduate Studies, Biomedical and Health Sciences

[4] Rutgers University,Center for Immunity and Inflammation, New Jersey Medical School

[5] Regional Bio-Containment Laboratory,Public Health Research Institute, New Jersey Medical School

[6] Center for COVID-19 Response and Pandemic Preparedness (CCRP2),Genome Editing Shared Resources, Cancer Institute of New Jersey

[7] Rutgers-New Jersey Medical School,undefined

[8] Rutgers University,undefined

来源：

Cell & Bioscience | / 12卷

关键词：

CD147; Basigin; hCD147KI; NSG; SARS-CoV-2; COVID-19; Viral entry; Accessory receptor; Immune responses; Spike protein; Knock-in mouse model; Physiological expression;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 50 条

[1] Development of a novel human CD147 knock-in NSG mouse model to test SARS-CoV-2 viral infection
Badeti, Saiaditya
Jiang, Qingkui
Naghizadeh, Alireza
Tseng, Hsiang-chi
Bushkin, Yuri
Marras, Salvatore A. E.
Nisa, Annuurun
Tyagi, Sanjay
Chen, Fei
Romanienko, Peter
Yehia, Ghassan
Evans, Deborah
Lopez-Gonzalez, Moises
Alland, David
Russo, Riccardo
Gause, William
Shi, Lanbo
Liu, Dongfang
CELL AND BIOSCIENCE, 2022, 12 (01):
[2] A novel hACE2 knock-in mouse model recapitulates pulmonary and intestinal SARS-CoV-2 infection
Zhou, Xiaoyang
Sun, Weiyang
Zhang, Yu
Gu, Hongjing
Wang, Ruixuan
Xie, Peng
Zhu, Yunkai
Qiu, Minyue
Ding, Xiaoyan
Wang, Hui
Gao, Yuwei
Li, Jintao
FRONTIERS IN MICROBIOLOGY, 2023, 14
[3] CD147 inhibitors as a treatment for melanoma: Promising agents against SARS-CoV-2 infection
Pourani, Mohammad Reza
Nekooghadam, Sayyed Mojtaba
Youssefian, Leila
Vahidnezhad, Hassan
Abdollahimajd, Fahimeh
DERMATOLOGIC THERAPY, 2020, 33 (06)
[4] SARS-CoV-2 Entry: At the Crossroads of CD147 and ACE2
Fenizia, Claudio
Galbiati, Silvia
Vanetti, Claudia
Vago, Riccardo
Clerici, Mario
Tacchetti, Carlo
Daniele, Tiziana
CELLS, 2021, 10 (06)
[5] Human Basigin (CD147) Does Not Directly Interact with SARS-CoV-2 Spike Glycoprotein
Ragotte, Robert J.
Pulido, David
Donnellan, Francesca R.
Hill, Michelle L.
Gorini, Giacomo
Davies, Hannah
Brun, Juliane
McHugh, Kirsty
King, Lloyd D. W.
Skinner, Katherine
Miura, Kazutoyo
Long, Carole A.
Zitzmann, Nicole
Draper, Simon J.
MSPHERE, 2021, 6 (04) : 1 - 11
[6] CD147 mediates S protein pseudovirus of SARS-CoV-2 infection and its induction of spermatogonia apoptosis
Dai, Pengyuan
Ma, Chaoye
Jiang, Ting
Shi, Jianwu
Liu, Sha
Zheng, Meihua
Zhou, Yiwen
Li, Xiaofeng
Liu, Yang
Chen, Hao
ENDOCRINE, 2024, 85 (03) : 1435 - 1445
[7] Assessment of SARS-CoV-2 entry in gingival epithelial cells expressing CD147
Bontempo, Alexander
Chirino, Alexandra
Heidari, Alireza
Boparai, Saurav
Arora, Saher
Ruiz, Sunniva
Antonson, Sibel A. A.
Kawai, Toshihisa
Cayabyab, Mark J. J.
EUROPEAN JOURNAL OF ORAL SCIENCES, 2023, 131 (01)
[8] CD147 as an alternative binding site for the spike protein on the surface of SARS-CoV-2
Faghihi, H.
EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2020, 24 (23) : 11992 - 11994
[9] No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor
Jarrod Shilts
Thomas W. M. Crozier
Edward J. D. Greenwood
Paul J. Lehner
Gavin J. Wright
Scientific Reports, 11
[10] No evidence for basigin/CD147 as a direct SARS-CoV-2 spike binding receptor
Shilts, Jarrod
Crozier, Thomas W. M.
Greenwood, Edward J. D.
Lehner, Paul J.
Wright, Gavin J.
SCIENTIFIC REPORTS, 2021, 11 (01)

← 1 2 3 4 5 →